The long-term use of ipamorelin for increasing GH secretion has yet to be studied and findings are, at best, preliminary [11]
severe or persistent upper abdominal pain should prompt urgent medical assessment [10] [11] Dehydration and acute kidney injury (AKI): gastrointestinal fluid losses can lead to dehydration, which may precipitate AKI, particularly in those with pre-existing renal impairment or those taking nephrotoxic medicines Delayed gastric emptying: this may affect the absorption of orally administered medicines, including contraceptive pills and thyroid replacement therapy [11] Injection site reactions: redness, bruising, or discomfort at the subcutaneous injection site Heart rate changes: increases in resting heart rate have been noted with GLP-1 class agents [14] [15] Hypoglycaemia: particularly if used alongside insulin or sulphonylureas Potential pancreatitis risk: a class concern with GLP-1 receptor agonists
Low circulating IGF-1 levels are associated with increased risk of insulin resistance, metabolic syndrome, and type 2 diabetes development
CAN YOU COMBINE BPC-157 AND PRP
Meanwhile, BPC-157 sends out protective signals to shield cells from further damage
Glutathione and atherosclerosis Cardiovascular diseases are the leading causes of death in the US compared to any other cause (135)
